NewGenIvf Group Limited (NASDAQ: NIVF), a leading Asian fertility services provider, today launched a groundbreaking lifetime egg freezing service. This innovative “one charge, no worries” program offers women across Asia a single payment option for lifelong egg preservation.

BANGKOK, Jan. 13, 2025 — The service capitalizes on the significant growth of the egg freezing market in Asia. The global egg freezing and embryo banking market, valued at US$3.9 billion in 2022, is projected to expand at a 16.8% CAGR from 2023 to 2030 (source: independent third-party research report). NewGen’s lifetime plan is tailored to meet the needs of working women and professionals, eliminating recurring storage fees and time constraints.

NewGen projects US$12 million in annual revenue from this service in its first year. This launch coincides with increasing recognition of egg freezing as a valuable employee benefit, with some major Asian companies offering fertility preservation perks. Government support is also growing, as evidenced by Tokyo’s 2023 subsidy program partially covering egg freezing costs for residents, regardless of marital status.

NewGen will employ a comprehensive marketing approach, including strategic healthcare provider partnerships. Market research highlights significant potential in China, where a Beijing-based think tank’s study revealed over 60% of surveyed women (primarily aged 30-34 and highly educated) showed interest in egg freezing. Current Chinese regulations necessitate seeking such services from international providers like NewGen.

Mr. Siu Wing Fung Alfred, NewGen’s Founder, Chairman, and CEO, stated that this lifetime egg freezing service provides more accessible and worry-free fertility preservation for Asian women. He emphasized the service’s flexibility for career-focused women and its alignment with market demands, particularly among professional women. The company is well-positioned to become a leading regional provider of this crucial service.

About NewGen

NewGen is a comprehensive Asian fertility services provider assisting couples and individuals with fertility treatments. Dedicated to helping individuals build families, NewGen enhances access to infertility treatments and offers comprehensive services, including infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy (where legally permitted). NewGen operates clinics in Thailand, Cambodia, and Kyrgyzstan. For more information, visit [website address removed]. Information on NewGen’s website is not part of this press release.

Forward-Looking Statements

This press release includes forward-looking statements under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements, often including words like “believe,” “project,” “expect,” etc., involve risks and uncertainties. Actual results may differ significantly due to various factors, including the company’s ability to execute business plans, identify opportunities, meet financial projections, and navigate regulatory or competitive changes. Detailed risk factors are discussed in the Company’s annual report on Form 20-F and other SEC filings, available at www.sec.gov. Information provided is current as of the release date; no update obligation exists except as required by law.

Investor Relations Contact

ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: